These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. [Characteristics of ocular adnexal non-Hodgkin lymphoma]. Yi WS; Xu XL; Xiang Q; Jiang HB Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 33(9):826-30. PubMed ID: 18812662 [TBL] [Abstract][Full Text] [Related]
48. Prognostic factors for relapse and survival among patients with ocular adnexal lymphoma: validation of the eighth edition of the American Joint Committee on Cancer (AJCC) TNM classification. Kwon M; Lee JS; Lee C; Yoon DH; Sa HS Br J Ophthalmol; 2021 Feb; 105(2):279-284. PubMed ID: 32327417 [TBL] [Abstract][Full Text] [Related]
49. A Case Report of Conjunctival Extranodal Marginal Zone Lymphoma Treated with Intralesional Rituximab Injection Therapy. Yazicioglu T; Oklar M; Kocabas S; Karadag E; Elibol V; Tezcan ME Ocul Immunol Inflamm; 2022 Aug; 30(6):1329-1333. PubMed ID: 36084297 [TBL] [Abstract][Full Text] [Related]
50. TNFAIP3 is the target gene of chromosome band 6q23.3-q24.1 loss in ocular adnexal marginal zone B cell lymphoma. Honma K; Tsuzuki S; Nakagawa M; Karnan S; Aizawa Y; Kim WS; Kim YD; Ko YH; Seto M Genes Chromosomes Cancer; 2008 Jan; 47(1):1-7. PubMed ID: 17886247 [TBL] [Abstract][Full Text] [Related]
51. Treating synchronous bilateral ocular adnexal marginal zone lymphoma: the consortium for improving survival of lymphoma study. Oh SY; Kim WS; Kang HJ; Lee JH; Huh SJ; Kim SJ; Yoon DH; Hong JY; Lee WS; Kim HJ; Won JH; Park BB; Lee SI; Suh C Ann Hematol; 2018 Oct; 97(10):1851-1857. PubMed ID: 29947974 [TBL] [Abstract][Full Text] [Related]
52. [Efficacy of chemotherapy as a first-line treatment in patients with ocular adnexal MALT lymphoma]. Ning F; Ye J; Wei LQ; Li X; Wang JW Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):912-6. PubMed ID: 22931653 [TBL] [Abstract][Full Text] [Related]
53. Unilateral isolated extraocular muscle lymphoma. Byard SD; Chowdhury HR; Lee RM; Hyer J; Hart-George AL BMJ Case Rep; 2012 May; 2012():. PubMed ID: 22669857 [TBL] [Abstract][Full Text] [Related]
54. Spontaneous regression of bilateral conjunctival extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Matsuo T; Ichimura K; Yoshino T J Clin Exp Hematop; 2007 Nov; 47(2):79-81. PubMed ID: 18040147 [TBL] [Abstract][Full Text] [Related]
55. CD5-undetected by immunohistochemistry, t(11;14)(q13;q32)-positive conjunctival mantle cell lymphoma: a case report. Yoo SB; Kim YA; Jeon YK; Kim CW Pathol Res Pract; 2008; 204(10):779-83. PubMed ID: 18572329 [TBL] [Abstract][Full Text] [Related]
56. Treatment-associated outcomes of patients with primary ocular adnexal MALT lymphoma after accurate diagnosis. Masuda Y; Takeuchi K; Kodama T; Fujisaki T; Imaizumi Y; Otsuka E; Ozaki S; Hasebe S; Yakushijin Y Int J Clin Oncol; 2019 Dec; 24(12):1620-1628. PubMed ID: 31172332 [TBL] [Abstract][Full Text] [Related]
57. Local recurrence as immunoglobulin G4 (IgG4)-related disease 10 years after radiotherapy to ocular adnexal extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Matsuo T; Ichimura K; Yoshino T J Clin Exp Hematop; 2011; 51(2):125-33. PubMed ID: 22104312 [TBL] [Abstract][Full Text] [Related]
58. [MALT Lymphoma of the Conjunctiva in a 13-year old Child--5-Year Relapse-free Follow-up Following Antibiotic Treatment]. Höh H; Armbrust S; Decker T; Holland U; Balschat S Klin Monbl Augenheilkd; 2016 Jan; 233(1):79-84. PubMed ID: 26609671 [TBL] [Abstract][Full Text] [Related]
59. [Primary gastric lymphoma]. Barreda B F; Gómez P R; Quispe L D; Sánchez L J; Combe G J; Casanova M L; Celis Z J Rev Gastroenterol Peru; 2004; 24(3):238-62. PubMed ID: 15483686 [TBL] [Abstract][Full Text] [Related]
60. A case of conjunctival MALT lymphoma: successfully treated with solely extended rituximab therapy. Celiker H; Toker E; Kaygusuz Atagunduz I Int Ophthalmol; 2019 Mar; 39(3):687-691. PubMed ID: 29411260 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]